Centre for Virology,
Vaccinology and
Therapeutics
Developing novel treatments and vaccines for COVID-19, influenza and HIV
which affect millions of patients worldwide and are associated with serious public health and socioeconomic consequences
One programme is focused on vaccines for different respiratory viruses, including influenza and coronavirus
HIV vaccines are another focus
Two programmes focus on antivirals for respiratory viruses
One aimed at the host, the other at viral targets
The final programme is focused on improving diagnoses
scroll down
Health@INNOHK
Centre for Virology, Vaccinology and Therapeutics
Proactive and effective “surveillance and control” of epidemic infectious diseases outbreaks relies on the comprehensive knowledge of the viruses circulating in animals and human, reliable prediction of the potential of these animal viruses to jump interspecies barrier from animal to human, highly-multiplex diagnostic tests for rapid detection of these viruses in healthcare and field setting, broad spectrum antivirals for prophylactic and therapeutic treatment, and most importantly, a safe and towards-universal vaccine platform with heterologous protection against antigenically drifted viruses. Centre for Virology, Vaccinology and Therapeutics (CVVT) is set to provide these conditions.
Visit Our Website
MANAGING DIRECTOR
Professor Kwok-Yung YUEN
  • Chair of Infectious Diseases at the Department of Microbiology, The University of Hong Kong
  • Henry Fok Professorship in Infectious Diseases, The University of Hong Kong